Health Policy Reports

View Report

• Becerra Faces Confirmation Hearings, President Biden Nominates Chiquita
  Brooks-LaSure to lead CMS, Elizabeth Fowler for CMMI
• Hospital Groups Appeal 340B, Site Neutral Payment Rulings to the Supreme Court
• House Lawmakers Continue Work on COVID-19 Relief Bill
• Hospitals Push Back on Insurer White & Brown Bagging Practices
• Analysis: One-Third of Hospitals Not Complying with Price Transparency Rule
• Biden Administration Changes DOJ’s Position in Pending Supreme Court ACA
  Case

View Report

• Congressional Democrats Push Forward with Budget Reconciliation to Pass
  Biden’s COVID-19 Relief Package
• President Biden Issues Executive Order to Re-Open Federal Health Insurance
  Exchanges
• Medicare Part D Rebate Rule Delayed to 2023
• Incoming Senate Finance Chairman Ron Wyden Talks Drug Pricing Reforms
• CMS Issues Mid-Build Exception Determinations Under Site Neutral Law
• States Move Forward with Drug Importation, Reference Pricing Legislation
  Law

View Report

• Joseph R. Biden, Jr. Sworn in as 46th President of the United States
• Biden Administration Issues 60-Day Freeze on Pending & Recently-Finalized
  Regulations, Including Last-Minute Prior Authorization Rule
• Outgoing Trump Administration Finalizes 2022 Medicare Advantage/Part D Rule
• Pharmacy Benefit Manager Groups Sue HHS Over Drug Rebate Rule
• Federal Trade Commission Looks into Hospital Acquisitions of Physician
  Practices
• Drug Manufacturers Continue 340B Pharmacy Restrictions After HHS NonBinding Opinion as Additional Companies Join Legal Challenge

View Report

• HHS Won’t Appeal Rulings in Most Favored Nation Lawsuits
• Outcome of Georgia Run-offs Flips Senate to Democratic Control, Changing
  Healthcare Prospects
• HHS Secretary Alex Azar Renews COVID-19 Public Health Emergency
• Hospital Price Transparency Rule Goes into Effect
• HHS Sides with 340B Providers in Contract Pharmacy Dispute

View Report

• Lawsuits and Opposition to MFN Rule Continue to Pile Up
• Congress Strikes Deal on COVID-19 Relief Package, Omnibus Spending Bill
• Supreme Court Rules in Favor of Arkansas Law Regulating PBMs
• CMS Unveils Proposed Rule to Streamline Prior Authorization
• HHS Unveils HIPAA Reform Proposal
• HHS Finalizes 340B Dispute Resolution Rule as Hospital Groups Sue Over
  Program Enforcement
• JAMA Study Analyzes COVID-19 Infection Risk and Racial Disparities Among U.S.
  Cancer Patients

View Report

• The Network Featured in American Journal of Managed Care Article, Podcast
• President-elect Joe Biden Announces Nomination for HHS Secretary and Other
  Key Members of Health Team
• CMS Finalizes 2021 Physician Fee Schedule, Quality Payment Program and Hospital Outpatient Department & Ambulatory Surgery Center Payment Rules
• Contact Your Member of Congress to Stop Physician Payment Cuts
• Lawsuits Filed to Stop Trump Administration Most Favored Nation and Drug
  Importation Rules
• Congress Continues to Debate End-of-Year Spending Package, COVID-19 Relief
• White House Finalizes Overhaul of Stark Anti-Kickback Statues

View Report

• The US Oncology Network Issues Statement Warning “Most Favored Nation”
  Model Will Disrupt Cancer Care Access
• Administration Finalizes Regulations in “Midnight Rulemaking” Spree
• Provider Groups Urge CMS to Suspend Scheduled Medicare Payment Cuts
• Patient Groups Support Bill to Delay CMS Copay Coupon Rule
• Study Highlights Increased Risk Faced by Cancer Patients from COVID-19 as
  Vaccine Manufacturers Continue to Make Progress
• Study Finds Affordable Care Act Tied to an Increase in Early Cancer Diagnoses
• Supreme Court Hears Arguments on Lawsuit Challenging Constitutionality of the
  Affordable Care Act

View Report

• Joe Biden Elected 46th President of the United States
• President-Elect Biden Announces COVID-19 Advisory Board to Aid Transition Team
• The Network’s Dr. Marcus Neubauer and Ben Jones Discuss Impact of COVID-19 on Value-Based Care and Path Forward in AJMC Article
• Appeals Court Denies Hospitals’ Request to Revisit 340B, Site Neutral Payments Cases
• HHS Releases Insurer Price Transparency Final Rule
• JAMA: Independent Oncology Practices in the COVID-19 Era—Does U.S. Cancer Care Need a Bailout?
• USPSTF Issues Updated Draft Recommendations for Colorectal Cancer Screening

View Report

• The Network, Specialty Provider Groups Urge CMS to Waive Budget Neutrality in
  Final Physician Fee Schedule Rule
• The Network Outlines Concerns with Radiation Oncology Model in Letter to CMS
• Gridlock Over COVID-19 Relief Continues, Package Unlikely Before Election Day
• Amy Coney Barrett’s Judiciary Confirmation Hearings
• Supreme Court Hears Suit Over Arkansas PBM Law
• Concerns Mount Over Administration Proposal to Issue Prescription Discount
  Cards
• Humana Achieves Significant Cost Savings Moving Doctors Off Fee-for-Service
• CMS Announces 2021 Medicare Highlights as Open Enrollment Begins
• Lawmakers Solicit Recommendations for 340B Reform as Provider Groups Take
  Legal Action

View Report

• President Trump Makes Series of Health Care Announcements Ahead of Election
• Amy Coney Barrett Nominated to Replace Justice Ginsberg on the Supreme Court
• President Trump Signs Bill to Fund Government Through Early December, House
  Passes Updated COVID-19 Relief Package
• CMS Finalizes Radiation Oncology Model
• Dispute Over 340B Discounts Continues as HRSA, Lawmakers Weigh In
• New Research Highlights Impact of COVID-19 Pandemic on Cancer Cases, Health
  Disparities
• Pharmaceutical Executives Testify at House Oversight Committee Hearing

View Report

• White House Unveils Most Favored Nation Drug Pricing Executive Order, Expands
  Scope to Include Part D Drugs
• Partisan Divide Casts Bleak Outlook on Coronavirus Relief Deal Before November
  Elections
• Taskforce on Telehealth Policy (TTP) Releases Recommendations
• 340B Providers Plan Their Next Move As Congress Weighs In
• CMS Releases New Value Based Care Guidance for Medicaid
• Study Shows Substantial Increase in Healthcare Provider Consolidation
• Public Health Agencies Face Allegations of Political Interference

View Report

• The Network Shares Experience with Oncology Care Model Following Release of Latest Evaluation Report
• Senate Tees Up Vote on “Skinny” COVID-19 Relief Package
• Status of Administration’s Most Favored Nation Plan Remains in Limbo
• New Analysis Estimates Costs and Fiscal Impact of Biden Campaign’s Healthcare Plan
• CMS Proposes Pathway for Coverage of “Breakthrough” Devices and Technologies
• Tensions Continue Among 340B Program Stakeholders
• House Energy & Commerce Committee to Hold Public Hearing on FDA Independence, Pharma Companies Pledge to “Stand with Science” on COVID-19 Vaccines

View Report

• Biden Chooses Kamala Harris as Vice Presidential Running Mate
• No Agreement in Sight on Next Phase of COVID-19 Relief
• Federal Appeals Court Overturns North Dakota Law Regulating PBMs
• Drug Companies Seek Information on 340B Provider Discounts
• House Lawmakers Urge Leadership to Stop CMS’ Scheduled Reimbursement Cuts
  to Specialists
• CMS Announces New Alternative Payment Model for Rural Health

View Report

• Federal Circuit Court Rules CMS Has Authority to Implement 340B Payment Cuts
• President Signs “Buy American” Executive Order for Essential Medicines
• COVID-19 Relief Package Stalls in Congress; Trump Takes Executive Action
• The Network Responds to National Cancer Institute RFI on Cancer Care
  Telehealth
• Telehealth Update: President Signs Executive Order Expanding Telehealth
  Access, Legislation Gains Traction in Congress

View Report

• The Network Submits Comments on Medicaid Value-Based Purchasing
  Proposed Rule
• Congress Begins Discussions on Latest COVID-19 Relief Package
• CMS Administrator Verma Discusses Impact of Expanding Medicare
  Telehealth as Congress Weighs Legislative Action
• HHS Secretary Signs 90-Day Public Health Emergency Extension
• The Network Joins Coalition in Urging Top HHS Officials to Lift Prior
  Authorization Restrictions for Part B Drugs in Medicare Advantage Plans
• New Research Estimates Impact of Delayed Cancer Screenings

View Report

• The Network, McKesson Corporation Participate in Ad Campaign Encouraging
  Patients to Stop “Medical Distancing”
• The Network’s Dr. Amy McNally Discusses Negative Impacts of Delaying Cancer
  Care in AJMC Op-ed
• HHS Will Renew COVID-19 Public Health Emergency
• AMA-led Provider Letter Urges CMS to Waive Budget Neutrality Requirements in
  Physician Fee Schedule Rule to Prevent 2021 Provider Payment Cuts
• Paycheck Protection Program Deadlines Extended as Loan Data is Released
• Congress Update: Lawmakers Debate Next Pandemic Relief Package as Grassley
  Revives Drug Pricing Bill
• Providers, Lawmakers, HHS Support Making Telehealth Changes Permanent
• The Network Submits Comments to IPPS Proposed Rule

View Report

• The Network Urges Support for Bipartisan Bill to Improve CMMI
• Senate HELP Committee Holds Hearing on Telehealth
• CMS Proposal Encourages ‘Value-Based’ Drug Payments in Medicaid
• Congress Update: House Passes ACA Expansion Bill, Revives Drug Pricing
  Proposal
• Federal Court Rejects Challenge to Hospital Price Transparency Rule
• Appeals Court Strikes Down Rule Requiring Drug List Prices in Ads
• NCI Director Sharpless Warns Recent Decline in Cancer Screenings Could Lead
  to Excess Cancer Death

View Report

• The Network Petitions Congress to Consider Additional Measures to Respond to
  COVID-19, Ease Burden on Community Cancer Care
• US Oncology Research Study Finds Cancer Drug May Benefit Advanced COVID-19 Patients
• CMS Announces Changes to OCM, Other CMMI Models
• HHS Reviewing Options to Expand Telehealth Flexibility Permanently
• Latest Jobs Report Shows Marked Healthcare Sector Improvements, Dentists
  Leading the Way
• Analysis Shows Slower Growth in Drug Prices
• Study Finds High Economic Cost Due to Racial Disparities in Cancer Deaths

View Report

• Study Finds Oncology Care Model Associated with Lower Healthcare Utilization
• COVID-19 Update: HHS Establishes June 3 Deadline for Providers to Request
  Additional Relief Payments & House Passes Revisions to Paycheck Protection
  Program
• CMS Finalizes MA and Part D Final Rule, Delays Changes to Drug Programs
• CMS Announces Plan to Lower Medicare Out-of-Pocket Costs for Insulin
• Report Finds Insurers Rarely Favor Biosimilars over Reference Biologics

View Report

• COVID-19 Legislative Update: Congress Back in Session, House Passes Sweeping Fifth Coronavirus Response Package
• CMS Releases FY 2021 IPPS & LTCH Proposed Rule, Hospital Groups Urge Court
  to Reject Price Transparency Measures
• CMS Finalizes Co-Pay Accumulator Policy in NBPP Rule
• Report Shows Critical Decline in Cancer Screenings

View Report

• Senate Returns to Discuss Fifth Pandemic Response Package
• CMS Announces Second Round of Regulatory Relief, Changes to the Advance &
  Accelerated Payments Program and Provider Relief Fund
• Members of Congress Urge Leadership to Prioritize DIR Fee Reform in Next
  Pandemic Relief Package
• Joe Grogan To Depart White House Domestic Policy Council
• HHS Delays Enforcement of Interoperability Rules
• HHS Urges Federal Appeals Court to Reinstate Site Neutral Payments
• CMS to Move Forward with Survey of 340B Hospitals’ Drug Acquisition Costs

View Report

• Update on CARES Act Relief
• Congress Working to Boost Funding for Paycheck Protection Program
• Medical Practices Continue to Struggle Amid COVID-19 Fallout
• NAACOS Survey Shows Majority of ACOs Likely to Leave Medicare
  Cost-Saving Programs Due to COVID-19 Concerns
• COVID-19 & Cancer Care: Practices Adjust, New Guidelines, and A
  Patient Registry
• CMS Boosts Medicare Advantage and Part D Payment Rates for 2021
  Coverage Year
• Administration Draws Strong Opposition from Stakeholders in
  Response to Drug Pricing Proposals Designed to Boost Generics and
  Biosimilars

View Report

• The US Oncology Network Submits Letter to HHS Secretary Alex Azar Requesting Relief for Community Oncology Providers
• The Network Submits Comments on 2021 and 2022 Medicare Advantage and Part D Proposed Rule
• Congress Begins Discussions on Phase Four COVID-19 Relief Bill
• Administration Rejects ACA Special Enrollment Period as Some States Re-Open
  Their Own Exchanges
• COVID-19 Puts Strain on Independent Medical Practices
• Drug Pricing Legislation Not Included in Latest COVID-19 Relief Bill, Next
  Opportunity Likely Post-Election
• Study Finds Oncology Clinical Pathways Decrease Costs in Oncology-Specific
  APMs
• CMS Defends Price Transparency Rule in Federal Court

View Report

• President Declares National Emergency for COVID-19
• Congress Passes Second COVID-19 Response Package, Prepares Phase Three
• CMS Releases Recommendations on Elective Surgeries During COVID-19 Response
• White House Releases Drug Pricing Principles, CBO Releases Score for Senate Finance Committee Bill
• New Medicare Part D Model for Insulin Released
• HRSA to No Longer Issue 340B Guidance, Citing Limited Authority
• NCCN Releases Recommendations for Standardizing Quality Measurements in
  Oncology
• Report Shows Decline in Cancer Death Rates

View Report

• The Network Urges CMS to Drop Copay Accumulator Provision from
  2021 NBPP Proposed Rule
• Dr. Thaker Discusses How Practices Can Use Big Data Analytics to Prepare for Proposed Radiation Oncology Model in Journal of Oncology Practice
• Congress Passes Supplemental Funding Bill to Address COVID-19 as Federal Agencies Release Updates
• CMS and ONC Release Healthcare Interoperability Rules, HHS Releases Strategy to Reduce EHR Administrative Burdens
• New Research Shows Pharmacy DIR Fees Hit a Record $9 Billion in 2019
• CMS Enables States to Restructure Medicaid Program Benefits
• Study Finds Medicaid Expansion Fails to Spur More Hospital Charity
  Care Spending
• FDA, FTC Outline Steps to Deter Anticompetitive Practices in
  Biosimilar/Biologic Advertising
• Supreme Court Will Hear Third Challenge to Affordable Care Act

View Report

• Dr. Neubauer Commentary Highlights The Network’s Oncology Clinical Pathways
• New Rule Would Enable Medicare Part D Plans to Create Preferred Specialty Drug Tiers in to Help Lower Out-of-Pocket Costs
• Secretary Azar Defends Administration Budget Request Before Senate Finance Committee
• CMS Leader Hints at Reforming Prior Authorization Requirements
• CMS Releases Proposed Three-Year Extension of Comprehensive Care for Joint Replacement Model
• Report Shows Americans with Employer Coverage Saw Growth in Drug Spending That Outpaced Other Medical Costs
• Commentary Highlights Forthcoming Expansion of Biosimilars

View Report

• The Network’s Debra Patt, MD Raises Step Therapy Concerns
• President Renews Call for Drug Pricing Reform, Highlights Other Healthcare Issues in State of The Union
• Administration Unveils 2021 Budget Proposal
• Lawmakers Introduce Bill to Increase CMMI Transparency
• Ways and Means Health Subcommittee Holds Hearing on Drug Pricing
• CMS Enables States to Restructure Medicaid Program Benefits
• CMS Clarifies Use of Copay Accumulators
• FDA, FTC Outline Steps to Deter Anticompetitive Practices in Biosimilar/Biologic Advertising
• CMS Expands Coverage of Next Generation Sequencing Diagnostic Tests
• Insurer Groups, CMS Announce Efforts Aimed at Improving Prior Authorization

View Report

• Hospital Groups Sue Over 2020 Site Neutral Payment Cuts
• Supreme Court Will Weigh Validity of State Laws Regulating PBMs
• Report Finds Significant Variability in Oncology Drug Costs Across Sites of Service
• GAO Report Faults HRSA for Lapses in 340B Program Oversight
• MedPAC Issues Payment Recommendations, 340B Study Following January Meeting

View Report

• Texas Oncology’s Dr. Wilfong Co-Authors Commentary on Patient- Reported Outcomes in Medicare Oncology Payment Models
• Network Members Discuss Proposed Radiation Oncology Model in JCO Oncology Practice Blog
• The Network Responds to Cures 2.0 RFI
• President Signs End of Year Spending Deal; Tees Up Health Legislation in Spring
• Brad Smith Named New Head of CMMI
• Avalere Releases Analysis on Part D Formularies
• Study Finds 340B Hospitals Reimbursed at a Higher Rate Than What They Pay for Drugs
• Study Finds Increase in Hospital Mergers Has Not Led to Improvements in Quality

View Report

• Medicare Part B Premiums to Increase in 2020
• CMMI Extends Oncology Care First Model Comment Deadline to December 13
• HHS Defends 340B Payment Cuts in Court
• MedPAC Highlights Hospital Consolidation in New Analysis
• HHS Releases Price Transparency Rules
• Op-ed: Reforming CMMI is Not a Partisan Issue
• Stephen Hahn Nominated to FDA Commissioner

View Report

View Report

View Report

• New CMS Rule to Impede Drug Company Coupon Practices
• Grassley Seeks Deal with House Dems To Press McConnell On DrugPricing Vote
• Canada Reacts to U.S. Import Plan After Meeting with Stakeholders
• Court Consolidates Hospitals’ Site Neutral Payment Lawsuits
• Surprise Billing Debate Wages On
• Radiopharmaceutical Payment Equity Act Introduced in House

View Report

• The Network Responds to CMS’ Patients Over Paperwork Initiative
• CMS Issues National Coverage Determination for CAR-T Therapy
• ASP Coalition Commends Senate Finance Committee Members for
  Opposing IPI
• John O’Brien, Senior Advisory to the Secretary on Drug Pricing
  Reform, to Leave HHS
• GAO Report Finds Part D Drug Rebates Growing Fast; PBMs Give
  Nearly All Rebates To Plan Sponsors
• UnitedHealth Group Analysis on Rising Cost of Hospital Care

View Report

• The Network’s Dr. Patt Discusses the Oncology Care Model
• CMS Proposes Mandatory Radiation Oncology Bundled Payment Model
  as Head of CMMI Announces Departure
• Judge Blocks HHS Rule Requiring Drug Companies to List Prices in TV
  Ads
• Administration Abandons Proposal to Eliminate Certain Drug Rebates
• HHS Secretary Azar Shifts on Drug Importation
• CMS Releases Quality Payment Program Results
• Federal Appeals Court Hears Arguments on the Constitutionality of the
  Affordable Care Act

View Report

• Ben Jones: Oncologists Still Face Challenges When Trying to Extract Data From EHRs
• House GOP Doctors Caucus Sends Letter to HHS Secretary Over Step Therapy Concerns
• President Trump Issues Executive Order on Pricing Transparency
• CAP Study Confirms High Price of Hospital Care
• Senate Judiciary Committee Advances Prescription Drug Pricing Legislation
• Lower Health Care Costs Act Passes Committee

View Report

• The Network’s Ben Jones Discusses the Impact of Step Therapy in Medicare Advantage
• Bipartisan Bill to Improve Prior Authorization Transparency Introduced in House
• Drug Pricing Legislation Update: Cassidy Introduces Bill Package, Promotes Value-Based Payments
• CMS Seeks Fresh Ideas On How To Reduce Provider Administrative Burdens
• Senate Judiciary Subcommittee Holds Hearing on Healthcare Consolidation
• House Ways & Means Committee Holds Hearing on Universal Healthcare
• Pharmaceutical Companies Invest Heavily in Cancer Treatments
• Merck, Lilly and Amgen Sue HHS Over Drug Prices in Ads

View Report

• The Network Hosts Congressman Kevin Brady for Employee Town Hall
• CMS Releases 2020 Medicare Advantage and Part D Drug Pricing Final Rule
• Senate HELP Committee Unveils Bipartisan Healthcare Legislation
• House Energy &Commerce Committee Holds Hearing on Drug Pricing Bills
• House Committees on Energy & Commerce and Ways & Means Release Draft Legislation to Reform Medicare Part D
• CMS Delays CAR-T Coverage Policy

View Report

• The Network’s Dr. Patt Featured in the Austin American-Statesman
• New Court Ruling Orders CMS to Quickly Rectify 340B Pay Cuts
• FDA Issues Final Rule on Biosimilars
• CMS Finalizes Rule Requiring Drug Prices in Direct-to-Consumer Ads
• House Lawmakers Launch Effort to Block Site Neutral Payments
• Forty-Four States Sue Generic Drug Makers, Allege Price-Fixing
• Senate Judiciary Committee Examines Drug Patents
• Energy & Commerce Subcommittee on Health Holds Hearing on Drug Supply Chain

View Report

• Congressman Mike Waltz Visits Southeast Regional Prostate Cancer Treatment Center
• The Network Joins Physician Groups in Opposing Repeal of the Stark Law’s In-Office Ancillary Services Exception
• ASTRO Survey of Radiation Oncologists Finds Prior Authorization Unnecessarily Delays Patient Access to Care
• CMMI Unveils New Primary Care Pilot Programs to Reform Payment to Providers
• House Rules Committee Holds Hearing, CBO Releases Report on Medicare for All
• House Energy and Commerce Holds Hearing on Prescription Drug Pricing in the Medicare Program
• House Judiciary Committee Marks-Up Drug Pricing Bills

View Report

• IPI Model Continues to Pose Threat to Delivery of Community Based Cancer Care
• Members of Congress Tour Local Oncology Practices
• Bipartisan Bill to Limit Step Therapy Introduced
• Site Neutral Payments Lawsuit: Hospitals Argue CMS Can’t Ignore Statue
• Senators Question PBM Executives at Finance Committee Hearing
• Drug Price Transparency Bill Passes House Ways and Means Committee
• Medicare Expected to Announce CAR-T Coverage Decision Soon
• CMS Announces ACO Application Timeline to Begin in 2020
• Sanders Reintroduces Medicare for All Bill in the Senate

View Report

• Members of Congress Urge Azar to Reconsider IPI Drug Pricing Model
• Alliance for Site Neutral Payment Reform Hosts Capitol Hill Briefing
• McKesson’s Ben Jones Discusses Cancer Care Policies with AJMC
• Department of Justice Argues Court Should Strike Down Entire ACA
• Federal Court Strikes Down Association Health Plan Rule
• House Energy & Commerce Committee Holds Mark-up Hearing on Drug Pricing Bills
• Energy & Commerce Subcommittee Chair: No Plans for 340B Oversight Hearings

View Report

View Report

View Report

View Report

• The Network Submits Comments on Proposed IPI Drug Pricing Model
• MedPAC Releases Comments on Proposed IPI Model
• Federal Court Strikes Down CMS 340B Drug Cuts
• Pelosi Sworn in as Speaker of the House
• House Ways & Means Committee Leadership Urges Greater Transparency in CMMI Reform
• Senators Urge CMS to Establish Guardrails for Step Therapy Policy
• Government Shutdown Impacts & Updates
• Texas ACA Case Under Appeal
• Senate Confirms New Science Advisor and Drug Czar

View Report

• Conservative Lawmakers, Groups Oppose the International Pricing Index
  (IPI) Model
• Alliance for Site Neutral Payment Reform Submits Comments on Final
  OPPS Rule
• Hospital Groups File Lawsuit to Stop Site Neutral Payments for E/M
  Services
• New HHS Report on Health Care Competition Urges Congress to Expand
  Site Neutral Payments
• HRSA to Implement 340B Ceiling Price Rule in January 2019
• Supreme Court to Hear Case On CMS’ Rulemaking Authority on January 15
• Democrats Nominate Nancy Pelosi as Candidate for House Speaker

View Report

• House E&C Republican Pushes Back on International Price Index, Opposes Price Fixing
• CMS Administrator Seema Verma Discusses International Price Index
• AMA Resolutions Support Site Neutral Payments, Call for More 340B Program Transparency
• Oncologists Concerned by HHS Plans to Launch Mandatory Radiation Demo
• Senator Chuck Grassley to Chair Senate Finance Committee

View Report

• 2018 Midterm Election Results
• The Network Responds to International Pricing Index Model for Medicare Part B Drugs
• Site Neutral Provisions Included in Final OPPS Rule
• CMS Releases Physician Fee Schedule Final Rule; Delays Payment Changes to E/M Visits
• HHS Announces New Radiation Oncology Alternative Payment Model
• In Letter to CMS, Congressman Holding Expresses Concern about Step Therapy in MA Plans

View Report

• CMS Announces International Pricing Index (IPI) Model for Medicare Part B Drugs
• Lawmakers, Stakeholders Call on Administration to Rescind Step Therapy Proposal
• The US Oncology Network Announces Highly Positive MIPS Results for 2017
• President Trump Signs Package of Legislation to Combat Opioid Crisis
• Trump Administration Issues New Requirements for Drug Advertising
• Bipartisan Group of Lawmakers Urges CMS to Issue Guidance on Prior Authorization
• Mississippi and Colorado Medicaid Programs Require Hospitals to Provide More Information on 340B Drugs
• Senate, House Party Control Up for Grabs in Looming Midterm Election

View Report

• Senate Passes Historic Opioid Legislation Sending Final Bill to President
  Trump
• House Passes $854B Spending Bill to Avert Shutdown
• CMS Announces Participants in New Value-Based Bundled Payment Model
• CMS to Strengthen Oversight of Medicare’s Accreditation Organizations
• CMMI Chief Adam Boehler Comments on ACO Participation
• CMS Updates Local Coverage Determination Process

View Report

• US Oncology Network PAC Board Visits Capitol Hill
• Members of Congress Tour Local Oncology Practices
• The Network, Alliance for Site Neutral Payment Reform Submit Comments on OPPS Rule
• ASP Coalition Hosts Hill Briefing on Step Therapy Challenges
• Congress Reaches Deal on Opioids Package
• American Hospital Associate Unveils 340B Good Stewardship Principles
• Rep. Delbene Circulates Letter Urging CMS to Expand MIPS Low-Volume Threshold
• Bills Banning PBM “Gag Clauses” Headed for President’s Signature

View Report

• The Network Submits Physician Fee Schedule Comments, Expresses
  Concern with Proposed E/M Service Cuts
• 240 Stakeholder Groups Call on Congress to Ask CMS to Reverse Step
  Therapy Proposal
• CMS to Allow Indication-Based Formulary Design for Part D Plans
• Hospital Groups Refile Lawsuit to Challenge 340B Cuts, Force
  Implementation of Ceiling Pricing Rule
• PhRMA Report Finds Hospitals Mark-up Prescription Drugs by up to 500
  Percent
• E&C Leaders Seek More Information on Role of PBMs in Impacting Drug
  Prices
• House E&C Committee Advances PBM Gag Clause Ban

View Report

• The Network Responds to Health Care Innovation Caucus RFI on Value- Based Provider Payment Reform
• Congressman Erik Paulsen Visits Minnesota Oncology
• House Energy & Commerce and Senate HELP Committee Leaders Urge Effective Administration of 340B Drug Pricing Program
• HHS Issues Report on Administration’s Drug Pricing Actions to Date
• Senate Passes HHS Spending Bill
• HHS OIG issues Request for Information on Changes to Anti-Kickback Statute Safe Harbors
• Senate Plans to Act on Opioid Legislation Post-Labor Day

View Report

• Brookings Institution Calls for Expansion of Medicare Site Neutral Payment Policies
• CMS to Require ACOs to Take on More Risk
• CMS Releases New Step Therapy Guidance for Medicare Advantage Plans
• Bipartisan House Lawmakers Urge HHS to Address Retroactive DIR Fees
• Senator Hatch, Rep. Walden Urge OMB to Fully Consider Safe Harbor Proposed Rule
• E&C Leaders Request Additional Info From 340B Contract Pharmacies
• Bipartisan House Committee Leaders Send Letters to Opioid Manufacturers

View Report

• Site Neutral Payments, Further Cuts to 340B Included in OPPS Proposed Rule
• HHS Calls for Input on a Competitive Acquisition Program for Medicare Drug Procurement
• House Committees Hold Hearings on MACRA, Stark Law Reform
• HELP Committee Passes Bill to Ban PBM ‘Gag Clauses’
• House E&C Committee Requests FTC Review of PBM Mergers
• FDA Proposes Changes to Clinical Trial Review

View Report

• CMS Releases Proposed Medicare Payment Rules for 2019
• Dr. Debra Patt Testifies Before House Panel on 340B Reform
• The Network Offers Comments to CMS on CAR-T Therapies MSDRG Assignment
• Groups Submit Comments to Trump Administration Drug Pricing Plan
• President Trump Nominates Brett Kavanaugh to the Supreme Court
• Alex Azar Delivers Remarks at 340B Conference
• Appeals Court Denies Hospital Groups’ Challenge to 340B Cuts
• CMS Announces Demonstration Program that Would Exempt Doctors in At-Risk Medicare Advantage Programs from MIPS Participation
• FDA Administrator Gottlieb Delivers Remarks at National Comprehensive Cancer Network Policy Summit

View Report

• Secretary Azar Discusses Administration’s Drug Pricing Blueprint Before Senate HELP Committee
• Congresswoman Matsui Introduces Bill to Reverse 340B Cuts
• Senate HELP Committee Holds Hearing on 340B Drug Discount Program
• Administration Declines to Defend ACA’s Pre-existing Condition Ban in Federal Court
• Administration Issues Association Health Plan Final Rule
• House Passes Dozens of Bills to Address Opioid Crisis
• SNIH Leaders Outline Plan to Fight Opioid Epidemic

View Report

• A Message from The Network About “Right to Try”
• COA Sues HHS For Applying Sequestration to Part B Drugs
• HRSA Officially Delays 340B Penalties Rule
• Senate HELP Committee to Hold Hearing on 340B Drug Discount Program
• Bipartisan Bill to Lower Part D Drug Prices Introduced in the House
• CBO Report Finds President’s FY 2019 Budget Would Reduce Federal Health Care Spending by $1.3 Trillion
• Senator Bill Cassidy Presents Health Care Reform Ideas in White Paper
• Report Finds Drug Spending Doubled in the Past Five Years, Expected to Double Again in the Next Five Years

View Report

• Administration Releases Drug Pricing Proposal
• CMS Releases Updated Drug Spending Dashboard
• CMS Urges Medicare Part D Plans to Stop Using Pharmacy Gag Orders
• COA Survey Highlights Physician Concerns with Part B Reform Proposals
• House Passes Right to Try Bill, Sending it to President Trump’s Desk
• House Energy & Commerce, Ways & Means Committees Advance Additional Bills to Combat Opioid Abuse
• Senate HELP Committee Hearing Examines Oversight of the 340B Drug Discount Program

View Report

• Representative Scott Taylor Visits Virginia Oncology Associates
• President Trump to Deliver Speech on Drug Pricing This Friday
• HHS Secretary Azar, CMS Administrator Verma Deliver Remarks Before the American Hospital Association
• Alliance for Site Neutral Payment Reform Applauds Republican Study Committee Budget
• HRSA Delays 340B Rule for a Second Time
• Federal Appeals Court Hears Oral Arguments in 340B Cuts Lawsuit
• Survey Reveals ACOs Have Significant Concerns About Risk, Would Prefer to Stay in Track 1
• McKesson Chairman Testifies at House Energy and Commerce Subcommittee Hearing

View Report

• Congressman Peter Roskam Visits Illinois Cancer Specialists
• The US Oncology Network Attends 2018 Community Oncology Alliance Annual Conference
• ASCO Analysis Demonstrates How Payment Bundles that Include Drug Costs May Destabilize Cancer Care Delivery
• CMS Releases FY2019 Inpatient Prospective Payment System Proposed Rule
• House Ways and Means Committee Holds Hearing on Innovation in Healthcare
• FDA Finalizes Guidance on Genetic Sequencing Development
• Poll Finds More Than Half of Americans Support Single Payer Healthcare

View Report

• House Speaker Paul Ryan Announces Retirement at End of Term
• HHS Announces Adam Boehler as Director of CMMI
• MedPAC Recommends Update to Physician Fee-for-Service
  Payment Rates
• 340B Update: CMS to Allow Medicare Advantage Plans That Contract with Hospitals to Negotiate 340B Rates, Delays Rule to Set New Drug Ceiling Prices
• Key Congressional Committees Hold Hearings on Opioid Legislation
• Nearly 12 Million People Signed up for Health Insurance on the Federal Exchange

View Report

• President Trump Signs $1.3 Trillion Omnibus Spending Bill
• CMS Finalizes Medicare Coverage for Gene Sequencing for Patients with Advanced Cancer
• Alliance for Site Neutral Payment Reform Issues Letter to Transparency Working Group
• Dr. Randolph Broun: The Biggest Threat to Local Cancer Care
• ASP Coalition Sends Letter to HHS Secretary Azar
• House Passes Right to Try Legislation, Senate Action Remains Unclear

View Report

• House Fails to Pass Right to Try Legislation
• Senate HELP Committee Hearing Examines 340B Program
• House, Senate Committees to Hold Hearings on Opioid Crisis
• FDA Administrator Criticizes PBMs in Recent Remarks
• HHS Secretary Azar Discusses Value-Based Care, Drug Pricing Transparency
• CMS Rejects Idaho’s Plan to Sell Non-ACA Compliant Insurance Plans

View Report

• HHS Releases Short-Term, Limited Duration Health Plans Proposed Rule
• CMS to Study Impact of MIPS on Clinicians
• Bipartisan Group of Governors Unveil Health Reform Blueprint
• Congress Holds Hearings on the Opioid Crisis, Bipartisan Treatment Bill Introduced in the Senate
• New Study Examines Hospital Impact on Chemotherapy Spending

View Report

• Congress Passes, President Signs Bipartisan Budget Act of 2018; Key Provisions Support Community Oncology
• Administration Unveils FY 2019 Budget Request, Drug Price Proposals
• Azar Testifies on HHS’ FY 2019 Budget Request
• Hospital Group 340B Suit Granted Expedited Appeal

View Report

• Senate Finance Committee Advances Alex Azar’s Nomination
• The Network Urges Congress to Exclude Part B Drugs from MIPS Payment Adjustments
• Hospitals Groups to Appeal 340B Lawsuit Dismissal
• House Energy & Commerce Committee Releases Recommendations to Reform 340B Drug Discount Program
• CMS Introduces New Bundled Payment Model

View Report

• Federal Court Rejects Hospital Groups’ 340B Lawsuit
• Bipartisan Bill to Increase 340B Program Transparency Introduced in the House
• HHS Seeks Input from Stakeholders on How to Increase
  Competition, Expand Patient Choice in the Healthcare Marketplace
• President Trump Signs Tax Reform Legislation
• Congress Passes Short-Term Funding Package to Avert an End-of-Year Government Shutdown
• Senate Finance Committee Schedules Alex Azar’s Confirmation
  Hearing
• Senate Finance Committee Chair Orrin Hatch Announces Retirement

View Report

• Study Shows 340B Program Drives Patients into Hospital Settings, Increases Costs/li>
• MedPAC Recommends Replacing MIPS with Alternative Program
• CMS Cancels Mandatory Bundled Payments for Cardiac Care While Rolling Back the Comprehensive Care for Joint Replacement Program
• Fourteen Medical Societies Urge Congress to Protect Part B Therapy Access
• Senate HELP Committee Hearing Reviews Report on Drug Prices, House Energy & Commerce Committee Examines Drug Supply
  Chain
• CMS Releases 2016 National Health Expenditures Report

View Report

• The US Oncology Network, Alliance for Site Neutral Payment Reform Submit Comments on CMMI Reform
• HHS Secretary Nominee Alex Azar Testifies Before Senate HELP Committee
• CBO Analysis Says Tax Bill Will Trigger $25 Billion in Medicare Cuts
• Bipartisan Bill Introduced to Block 340B Cuts

View Report

• Alex Azar Nominated to be Next HHS Secretary
• House Energy & Commerce Committee Holds Hearing on
  Alternative Payment Methods
• New CBO Analysis Finds Repealing the ACA Individual Mandate Would Save $338 Billion
• Physicians Advocacy Institute Study Examines Hospital
  Employment of Physicians
• CMMI Report Outlines Episode-Based Payment Model for
  Radiation Therapy
• Hospital Groups File Lawsuit over 340B Program Cuts
• 113 Healthcare Stakeholders Send Letter Urging Seema Verma to Implement CMMI Guardrails

View Report

• The US Oncology Network PAC Board Meets with Healthcare Policymakers in DC
• House Energy & Commerce Oversight Subcommittee Examines 340B Drug Discount Program
• President Trump Issues Healthcare Executive Order
• Trump Administration Terminates CSR Payments
• Trump Names Hargan as Acting HHS Secretary
• NIH Partners with Pharmaceutical Companies on $215M Cancer Moonshot Initiative

View Report

• HHS Secretary Tom Price Resigns
• CMS Officially Withdraws Part B Drug Payment Demonstration
• Lawmakers Push for Delay of 340B Drug Cuts
• Graham-Cassidy Amendment Halts in the Senate, Repeals Future Now Uncertain
• House, Senate Unveil Competing Fiscal Year 2018 Budget Resolutions

View Report

• Alliance for Site Neutral Payment Reform Submits Comments to CMS Payment Rules
• Lawmakers Thank HHS Secretary Price for Terminating the Medicare Part B Payment Model
• Senate Republicans Move Forward with Latest ACA Repeal Attempt
• CMS Announces “New Direction” for Innovation Center, Launches an Informal Request for Information
• House Energy & Commerce Committee Advances Healthcare Bills to Mirror CHRONIC Care Act
• House Ways & Means Committee Advances Stark Administrative Simplification Act
• AACR Releases 2017 Cancer Progress Report

View Report

• The Network Submits Comments on CMS CY 2018 Quality Payment Program Proposed Rule
• The Network Responds to House Ways & Means Committee “Medicare Red Tape Relief Project” Request for Feedback
• Senate HELP Committee to Hold Hearings on Bipartisan ACA Fix
• Anthem Suspends Payment for In-Hospital MRI and CT Scans Performed on an Outpatient Basis
• New Studies Show Adverse Effects of Hospital-Physician Practice Consolidation
• CMS Advisory Panel Recommends Against Cuts to Hospital 340B Reimbursement
• HHS Office of the Inspector General Releases Two Medicare Part B Payment Reports

View Report

• Senate Efforts to Repeal and Replace Affordable Care Act Fall Short
• The Alliance for Site Neutral Payment Reform Endorses Site Neutral Provision in FY2018 Physician Fee Schedule Proposed Rule
• House Ways & Means Committee Announces Red Tape Relief Projects to Reduce Medicare Barriers
• Medicare Part B Bill Passes in the U.S. House
• CMS Unveils Latest Update to Its Market Saturation and Utilization Data Tool

View Report

• CMS Releases Proposed Medicare Payment Rules, HOPPS Rule Includes Proposal to Significantly Reduce 340B Drug Reimbursement
• House Energy & Commerce Hearing Holds 340B Drug Pricing Program Hearing
• Future of Senate Healthcare Bill Remains Unclear
• The US Oncology Network Joins Patient Advocates, Provider Groups in Support of Bipartisan Senate Prompt Pay Bill
• House Budget Committee Unveils FY2018 Budget Resolution
• Medicare Trustees Release Annual Report, Delay IPAB Trigger Until at Least 2019

View Report

• Network Physician and Clinicians Pen Column on Cancer Care Transitions
• Senate GOP Releases Health Care Bill, Vote Postponed
• CMS Releases Proposed MACRA Rule
• MedPAC Issues Its June 2017 Report to Congress

View Report

• The Network Joins 268 Groups Calling on Secretary Price to Protect Medicare Part B
• CMS Releases Estimated Financial Effects of the American Health Care Act
• HHS Secretary Price Testifies Before Congress on FY18 HHS Budget
• Senate HELP Committee Holds Hearing on Drug Pricing Reform
• American Medical Association Names Community Oncologist as President-Elect
• American Medical Association Study: Fewer Than Half of Physicians Owned their Own Practices in 2016
• New NCI Director Selected, NIH Director Stays in Place

View Report

• House Advances AHCA
• President Trump Releases Budget Blueprint
• Seema Verma Confirmed as CMS Administrator
• Health Resources and Services Administration Delays 340B Rule
• MedPAC Releases Report to Congress; Reiterates Site Neutral Recommendations

View Report

• House Republicans Introduce ACA Repeal and Replace Bill
• Seema Verma Approved by Senate Finance Committee
• MedPAC Discusses Part B Drug Reimbursement

View Report

• McKesson Specialty Health Leaders Author AJMC Column on the Emerging Role of Immuno-Oncology Agents
• Bipartisan Legislation Aims to Tackle DIR Fees
• Tom Price, MD Confirmed as HHS Secretary
• CMS Nominee Testifies Before Senate Finance Committee
• House Republicans Release ACA Replacement Plan

View Report

• President Trump Signs Executive Order Facilitating ACA Repeal
• Congress Passes Budget Resolution with ACA Repeal Instructions
• Senate Holds Confirmation Hearings on Congressman Tom Price as HHS Secretary
• January MedPAC Meeting Focuses on Physician Payment

View Report

• The US Oncology Network Meets with Cancer Moonshot Leaders
• Congress Kicks Off Lame Duck Session
• President-Elect Trump Taps Former Officials for HHS Transition
• MedPAC Holds Meeting on Provider Consolidation

View Report

• CMS Releases Final Medicare Payment Rules for 2017
• Alliance for Site Neutral Payment Reform Commends CMS for Finalizing Site Neutral Policy in HOPPS
• CMS Re-opens Applications for Certain APMS, Extends Oncology Care Model’s Availability to Cover 2017 Performance Year
• Senate Finance Members Released Bipartisan Proposal on Chronic Care Improvement
• CBO Submits Answers on Budgetary Effects of the Center for Medicare & Medicaid Innovation